Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT1A receptor antagonism and serotonin reuptake inhibition was discovered. 1-(1H-Indol-4-yloxy)-3-(4-benzo[b]thiophen-2-ylpiperidinyl)propan-2-ols exhibited selective and high affinities at the 5-HT1A receptor and serotonin reuptake site in vitro. In vivo evaluation of this series of compounds demonstrated elevated extracellular serotonin levels from the basal and quick recovery of neuron firing that was presumably suppressed by the initial acute activation of 5-HT1A somatodendritic autoreceptors.

Knowledge Graph

Similar Paper

Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5
Bioorganic & Medicinal Chemistry Letters 2006.0
New 1-Aryl-3-(4-arylpiperazin-1-yl)propane Derivatives, with Dual Action at 5-HT<sub>1A</sub>Serotonin Receptors and Serotonin Transporter, as a New Class of Antidepressants
Journal of Medicinal Chemistry 2001.0
Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT<sub>1A</sub>and Serotonin Transporter Affinity within a Class ofN-Aryloxyethylindolylalkylamines
Journal of Medicinal Chemistry 2004.0
Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives
Bioorganic &amp; Medicinal Chemistry 2008.0
Discovery of the First Potent, Selective 5-Hydroxytryptamine<sub>1D</sub> Receptor Antagonist
Journal of Medicinal Chemistry 2005.0
Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7
Bioorganic &amp; Medicinal Chemistry Letters 2019.0
Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT<sub>1A</sub>Receptor Antagonists
Journal of Medicinal Chemistry 2009.0
Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2002.0
3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT 1A /5-HT 7
European Journal of Medicinal Chemistry 2018.0